Announcement PDF NEUREN PHARMACEUTICALS LIMITED RESULT OF ANNUAL GENERAL MEETING (ASX REPORT) ANNUAL GENERAL MEETING Tuesday, 28 May, 2024 As required by section 251AA(2) of the Corporations Act 2001 (Commonwealth) the following statistics are provided in respect of each resolution on the agenda. Resolution Voted on at the meeting 2 Total votes cast in the poll (where applicable) Strike Y/N/NA For Against Discretionary (open votes) Abstain For Against Abstain ** Result RE-ELECTION OF PATRICK DAVIES AS A DIRECTOR NA 47,235,712 2,544,453 127,604 36,302 51,338,336 2,544,453 36,302 Carried 94.65% 5.10% 0.26% 95.28% 4.72% AUDITOR FEES AND EXPENSES NA 49,169,654 598,915 129,451 53,274,125 598,915 46,051 Carried 98.54% 1.20% 0.26% 98.89% 1.11% No 1 Proxy Votes (as at proxy close) Short Description 46,051 ** - Note that votes relating to a person who abstains on an item are not counted in determining whether or not the required majority of votes were cast for or against that item Printed: 28/05/2024 This report was produced from the Link Market Services Meeting System Page 1 of 1